Abstract
To the Editor: Moreau and colleagues (August 11 issue)(1) found that, in patients with relapsed or refractory myeloma, treatment with teclistamab, a T......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
